Mouse Anti-LINGO2 Recombinant Antibody (CBYJL-1763) (CBMAB-L1673-YJ)

Li, D., Lian, L., Huang, L., Gamdzyk, M., Huang, Y., Doycheva, D., ... & Zhang, J. H. (2024). Delayed recanalization reduced neuronal apoptosis and neurological deficits by enhancing liver-derived trefoil factor 3-mediated neuroprotection via LINGO2/EGFR/Src signaling pathway after middle cerebral artery occlusion in rats. Experimental Neurology, 371, 114607.

Dudem, S., Boon, P. X., Mullins, N., McClafferty, H., Shipston, M. J., Wilkinson, R. D., ... & Hollywood, M. A. (2023). Oxidation modulates LINGO2-induced inactivation of large conductance, Ca2+-activated potassium channels. Journal of Biological Chemistry, 299(3).

Tomita, T., Yoshida, F., Nagatomo, R., Kimura, M., Shun, S., Nao, Y., ... & Lichtenthaler, S. (2023). Soluble form of Lingo2, an autism spectrum disorder-associated molecule, functions as an excitatory synapse organizer in neurons.

Chang, W. M., Li, L. J., Lin, C. H., Hsiao, M., & Chang, P. M. H. (2023). Abstract LB270: LINGO2-microRNA cluster controls oral cancer stemness ability and cancer progression. Cancer Research, 83(8_Supplement), LB270-LB270.

Soraya, G. V., Ulhaq, Z. S., & Garcia, C. P. (2021). Implication of the LINGO2 gene in the predisposition to movement disorders. Brain Science Advances, 7(4), 257-262.

Soraya, G. V., Ulhaq, Z. S., & Garcia, C. P. (2020). LINGO2 and movement disorder predisposition: Results of a meta-analysis. Available at SSRN 3691470.

Belle, N. M., Ji, Y., Herbine, K., Wei, Y., Park, J., Zullo, K., ... & Herbert, D. B. R. (2019). TFF3 interacts with LINGO2 to regulate EGFR activation for protection against colitis and gastrointestinal helminths. Nature communications, 10(1), 4408.

Jo, J. H., Park, S. B., Park, S., Lee, H. S., Kim, C., Jung, D. E., & Song, S. Y. (2019). Novel gastric cancer stem cell-related marker LINGO2 is associated with cancer cell phenotype and patient outcome. International journal of molecular sciences, 20(3), 555.

Su, T., Ren, Q., Lu, Y., Tai, W., Zhu, Y., Li, Z., ... & Ma, J. (2019). A genetic variant in LINGO2 contributes to the risk of gestational diabetes mellitus in a Chinese population. Journal of Cellular Physiology, 234(5), 7012-7018.

Ji, Y., Wei, Y., Park, J., Hung, L. Y., Young, T., Herbine, K., ... & Herbert, D. B. R. (2018). TFF3 is a ligand for LINGO2 that de-represses EGFR to control disease outcome during colitis and gastrointestinal nematode infection. BioRxiv, 469700.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-LINGO2 Recombinant Antibody (CBYJL-1765)

Mouse Anti-LINGO2 Recombinant Antibody (CBYJL-1766)

Mouse Anti-LINGO2 Recombinant Antibody (7H176)

Isotype control